ISIN | CH0016631365 |
---|---|
Valor Number | 1663136 |
Bloomberg Global ID | UBES3XC SW |
Fund Name | UBS (CH) Manager Selection Fund - Equities Switzerland XT3 I-X |
Fund Provider |
UBS Asset Management Switzerland AG
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG |
Representative in Switzerland | |
Distributor(s) | |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | N/A |
Peculiarities | In Liquidation |
Current Price * | 2,769.63 CHF | 17.12.2024 |
---|---|---|
Previous Price * | 2,762.47 CHF | 16.12.2024 |
52 Week High * | 2,911.00 CHF | 12.07.2024 |
52 Week Low * | 2,588.06 CHF | 09.02.2024 |
NAV * | 2,769.63 CHF | 17.12.2024 |
Issue Price * | 2,769.63 CHF | 17.12.2024 |
Redemption Price * | 2,769.63 CHF | 17.12.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 472,037,878 | |
Unit/Share Assets *** | 472,037,878 | |
Trading Information SIX |
YTD Performance | +5.94% |
29.12.2023 - 17.12.2024
29.12.2023 17.12.2024 |
---|---|---|
1 month | +0.87% |
18.11.2024 - 17.12.2024
18.11.2024 17.12.2024 |
3 months | -2.01% |
17.09.2024 - 17.12.2024
17.09.2024 17.12.2024 |
6 months | -2.29% |
17.06.2024 - 17.12.2024
17.06.2024 17.12.2024 |
1 year | +5.92% |
18.12.2023 - 17.12.2024
18.12.2023 17.12.2024 |
2 years | +10.06% |
19.12.2022 - 17.12.2024
19.12.2022 17.12.2024 |
3 years | -5.12% |
17.12.2021 - 17.12.2024
17.12.2021 17.12.2024 |
5 years | +18.17% |
17.12.2019 - 17.12.2024
17.12.2019 17.12.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 12.96% | |
---|---|---|
Nestle SA | 12.87% | |
Roche Holding AG | 12.58% | |
ABB Ltd | 5.59% | |
Zurich Insurance Group AG | 5.50% | |
UBS Group AG | 4.76% | |
Compagnie Financiere Richemont SA Class A | 3.55% | |
Swiss Re AG | 2.79% | |
Holcim Ltd | 2.74% | |
Givaudan SA | 2.10% | |
Last data update | 31.10.2024 |
TER | 0.00% |
---|---|
TER date | 31.10.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.96% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.11.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |